Insider · CIK 0001434718

Oliviero James F III

Reports to the SEC for 3 companies · FORT LEE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001434718

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+35K sh	—	—	122,828
2025-06-12	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	87,828
2025-05-30	Checkpoint Therapeutics, Inc.U Disposition from Tender	Director, CEO, President and Director	UDisposition from Tender	−3.76M sh	—	—	0
2025-04-02	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−15.1K sh	$4.04	−$61K	3,759,929
2025-02-10	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−10.3K sh	$3.15	−$32.5K	3,775,019
2025-02-07	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−9,233 sh	$3.41	−$31.5K	3,785,350
2025-01-30	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+1.5M sh	—	—	3,794,583
2024-12-20	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−900K sh	—	—	2,294,583
2024-12-19	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−220K sh	$3.38	−$744K	3,194,583
2024-12-18	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−602K sh	$3.87	−$2.33M	3,414,813
2024-12-13	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+2.08M sh	—	—	4,016,980
2024-06-26	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−37.9K sh	—	—	1,939,280
2024-06-26	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−24.6K sh	$2.05	−$50.5K	1,977,170
2024-06-13	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+30K sh	—	—	57,828
2024-05-24	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+1.66M sh	—	—	2,001,780
2024-02-28	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−5,894 sh	$2.06	−$12.1K	350,836
2024-02-28	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−9,056 sh	—	—	341,780
2024-02-01	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−13K sh	—	—	356,730
2024-02-01	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−11.9K sh	$2.01	−$23.9K	369,680
2023-08-16	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−12.5K sh	—	—	381,580
2023-06-16	NVCTNuvectis Pharma, Inc.A Award	Director	AAward	+18K sh	—	—	27,828
2023-03-31	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+250K sh	—	—	394,090
2023-03-02	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−5,483 sh	$5.00	−$27.4K	144,090
2023-02-27	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−5,548 sh	$4.65	−$25.8K	134,573
2023-02-27	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+15K sh	—	—	149,573
2023-02-24	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−42K sh	—	—	381,580
2023-02-01	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−10.3K sh	$4.77	−$48.9K	182,121
2023-01-10	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−3,817 sh	$6.75	−$25.8K	192,382
2022-09-26	Checkpoint Therapeutics, Inc.G Gift	Director, CEO, President and Director	GGift	−60K sh	—	—	196,199
2022-06-23	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−15K sh	$1.11	−$16.7K	2,562,003
2022-06-22	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−12K sh	$1.09	−$13.1K	2,577,003
2022-06-21	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−21K sh	$1.09	−$22.9K	2,589,003
2022-06-17	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−228K sh	$1.09	−$249K	2,610,003
2022-04-13	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−21.3K sh	$1.51	−$32.1K	2,838,003
2022-04-05	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−14K sh	$1.77	−$24.8K	2,859,261
2022-04-04	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−86.4K sh	$1.79	−$155K	2,873,291
2022-04-01	NVCTNuvectis Pharma, Inc. · Stock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-02-24	Checkpoint Therapeutics, Inc.F Tax Payment	Director, CEO, President and Director	FTax Payment	−118K sh	$1.85	−$218K	2,959,644
2022-01-31	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+455K sh	—	—	3,608,210
2022-01-30	Checkpoint Therapeutics, Inc.F Tax Payment	Director, CEO, President and Director	FTax Payment	−32K sh	$2.46	−$78.7K	3,077,301
2022-01-24	Checkpoint Therapeutics, Inc.F Tax Payment	Director, CEO, President and Director	FTax Payment	−143K sh	$2.19	−$313K	3,109,273
2022-01-06	Checkpoint Therapeutics, Inc.F Tax Payment	Director, CEO, President and Director	FTax Payment	−53K sh	$2.77	−$147K	3,252,409
2022-01-01	Checkpoint Therapeutics, Inc.F Tax Payment	Director, CEO, President and Director	FTax Payment	−303K sh	$3.11	−$942K	3,305,433
2021-02-05	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−48.8K sh	$3.42	−$167K	3,153,210
2021-02-04	Checkpoint Therapeutics, Inc.S Sale	Director, CEO, President and Director	SSale	−70K sh	$3.51	−$246K	3,202,000
2021-01-06	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+539K sh	—	—	3,272,000
2020-02-24	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+598K sh	—	—	2,733,000
2019-01-24	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+485K sh	—	—	2,135,000
2018-01-30	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+325K sh	—	—	1,650,000
2016-12-15	Checkpoint Therapeutics, Inc.A Award	Director, CEO, President and Director	AAward	+325K sh	—	—	1,325,000

Recent filings

Accepted (ET)
Jun 124
Oliviero James F III0001104659-26-073460
SEC(opens sec.gov)
Jun 124
Oliviero James F III0001104659-25-058916
SEC(opens sec.gov)
May 304
Oliviero James F III0001104659-25-054690
SEC(opens sec.gov)
Apr 34
Oliviero James F III0001104659-25-031813
SEC(opens sec.gov)
Feb 114
Oliviero James F III0001104659-25-011656
SEC(opens sec.gov)
Jan 314
Oliviero James F III0001104659-25-008258
SEC(opens sec.gov)
Dec 204
Oliviero James F III0001104659-24-130963
SEC(opens sec.gov)
Dec 174
Oliviero James F III0001104659-24-129525
SEC(opens sec.gov)
Jun 284
Oliviero James F III0001104659-24-076442
SEC(opens sec.gov)
Jun 134
Oliviero James F III0001104659-24-071284
SEC(opens sec.gov)
May 244
Oliviero James F III0001104659-24-065214
SEC(opens sec.gov)
Mar 14
Oliviero James F III0001104659-24-030149
SEC(opens sec.gov)
Feb 24
Oliviero James F III0001104659-24-010265
SEC(opens sec.gov)
Feb 25
Oliviero James F III0001104659-24-010262
SEC(opens sec.gov)

Companies

Address

C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275

FORT LEE, NJ, 07024